Pathology Doctors in Boulder, CO Accepting Medicare

8 Pathology doctors found. Showing 1 - 8

John E Meyer, M.D. Pathology - Clinical Pathology/Laboratory Medicine Medicare: Not Enrolled in Medicare Practice Location: 1100 Balsam Ave, Boulder, CO 80304 Phone: 303-440-2373

Kevin W Hanley, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 1100 Balsam Ave, Boulder, CO 80304 Phone: 303-440-2273

Elaine Z Allgood, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 1104 Juniper Ave, Boulder, CO 80304 Phone: 314-799-7831

William W Howland, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 1100 Balsam Ave, Boulder, CO 80304 Phone: 303-440-2320    Fax: 303-938-3182

Brooke Alt, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 1100 Balsam Ave, Boulder, CO 80304 Phone: 303-440-2273

Parker Wayne Clement, Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 4747 Arapahoe Ave, Boulder, CO 80303 Phone: 303-415-7000

Jason H Smouse, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 4747 Arapahoe Ave, Boulder, CO 80303 Phone: 303-415-7000

Robert C Forsythe, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 1100 Balsam Ave, Boulder, CO 80304 Phone: 303-440-2273

News Archive

John C. Lincoln Hospital first to use commercially-available LungPoint system

Broncus Technologies, Inc., a medical device company focused on developing minimally-invasive innovations for lung diseases, announced today at the American College of Chest Physicians CHEST 2009 meeting that John C. Lincoln Hospital in Phoenix is the first hospital in the U.S. to use the commercially-available LungPoint system.

HTDS finalizes contract details with Indian pharmaceutical company

Hard to Treat Diseases' (HTDS; http://www.htdsmedical.com/) operating subsidiary Mellow Hope finalized contract details with one of the largest manufacturer of intravenous medication in India.

Scientists uncover origin of Langerhans cells

Scientists at A*STAR's Singapore Immunology Network (SIgN) uncovered the origin of a group of skin-deep immune cells that act as the first line of defence against harmful germs and skin infections. SIgN scientists discovered that these sentry cells of the skin, called the Langerhans cells (LCs), originate from two distinct embryonic sites - the early yolk sac and the foetal liver.

Adolescent consumption of energy drink is strongly associated with substance use, says study

​Nearly one-third of US adolescents consume high-caffeine energy drinks or "shots," and these teens report higher rates of alcohol, cigarette, or drug use, reports a study in the January/February Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine.

InNexus Biotechnology, NCI amend Collaborative Agreement

InNexus Biotechnology Inc., a leading drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced the Company and the National Cancer Institute (NCI), part of the U.S. National Institutes of Health (NIH), have amended the Collaborative Agreement announced on May 27, 2010, involving research on technologies developed by InNexus.

Read more Medical News

› Verified 2 days ago